Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

PLoS medicine·2010

Same author

Physicians, the industry and population health.

Journal of epidemiology and community health·2009

Same author

Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.

BMC public health·2008

Same author

Is Australia's national medicines policy failing? The case of COX-2 inhibitors.

International journal of health services : planning, administration, evaluation·2007

Same author

The illusion of invulnerability.

BMJ (Clinical research ed.)·2007

Same author

Doctors as lapdogs to drug firms: Independence may be most cost effective way to improve health care.

BMJ (Clinical research ed.)·2006

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Do advertisements in clinical software influence prescribing?

Peter R Mansfield¹

¹Discipline of General Practice, University of Adelaide, Adelaide, SA, Australia. peter.mansfield@adelaide.edu.au

The Medical Journal of Australia

|January 22, 2008

Summary

This summary is machine-generated.

Pharmaceutical advertising benefits are presumed but lack clear definition and measurement methods. Further research is needed to quantify the impact of drug marketing strategies.

Related Experiment Videos

Last Updated: Jul 8, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Pharmaceutical Marketing
Health Economics
Advertising Research

Background:

Pharmaceutical companies invest heavily in advertising.
The precise benefits and measurement of this advertising are not well-understood.
Understanding advertising's ROI is crucial for strategic decision-making.

Purpose of the Study:

To explore the perceived benefits of pharmaceutical advertising.
To identify common methods used to measure advertising effectiveness in the pharmaceutical industry.
To highlight the ambiguities in quantifying advertising impact.

Main Methods:

Literature review of pharmaceutical marketing studies.
Analysis of industry reports on advertising expenditure and outcomes.
Qualitative assessment of measurement approaches.

Main Results:

Perceived benefits include increased brand awareness and market share.
Measurement methods are diverse, ranging from sales data to physician surveys.
A significant gap exists between claimed benefits and empirical evidence.

Conclusions:

The actual benefits of pharmaceutical advertising require more rigorous and standardized measurement.
Clearer metrics are needed to assess the return on investment for pharmaceutical marketing efforts.
Further investigation into effective advertising strategies is warranted.